Mayo Clinic Hematology & Medical Oncology Practice Updates and Board Review Online Course 2025
Mayo Clinic Hematology & Medical Oncology Practice Updates and Board Review Online Course 2025
Regular price
$110.00 USD
Regular price
$110.00 USD
Sale price
Unit price
/
per
Couldn't load pickup availability
Mayo Clinic Hematology & Medical Oncology Practice Updates and Board Review Online Course 2025
Regular price
$110.00
Regular price
$110.00
Sale price
Unit price
/
per
-
Share positive thoughts and feedback from your customer.
Author -
Share positive thoughts and feedback from your customer.
Author -
Share positive thoughts and feedback from your customer.
Author
Mayo Clinic Hematology & Medical Oncology Practice Updates and Board Review Online Course 2025
Information:Course opens: 08/28/2025
COURSE DIRECTORS: Kebede H. Begna, M.D., Tanios S. Bekaii-Saab, M.D., Naseema Gangat, M.B.B.S., Wilson I. Gonsalves, M.D., Thor R. Halfdanarson, M.D., Rami Manochakian, M.D., Sameer A. Parikh, M.B.B.S., and Kathryn J. Ruddy, M.D.
This online course offers up-to-date, practical information in hematology and medical oncology for immediate clinical use. It also provides high-yield content to help prepare for the ABIM initial and maintenance certification exams in both specialties.
This online course features repurposed content from the in-person Hematology & Medical Oncology Practice Updates and Board Review 2025 event.
This online course offers up-to-date, practical information in hematology and medical oncology for immediate clinical use. It also provides high-yield content to help prepare for the ABIM initial and maintenance certification exams in both specialties.
This online course features repurposed content from the in-person Hematology & Medical Oncology Practice Updates and Board Review 2025 event.
Target Audience
This activity is appropriate for physicians and resident fellows.
This activity is appropriate for physicians and resident fellows.
Learning Objectives
- Recognize evidence-based practices for managing patients with bleeding and/or clotting disorders.
- Identify appropriate molecular tests, such as next-generation sequencing, for cancer diagnosis.
- Recognize how to incorporate the most current cancer treatment options, such as immunotherapy or targeted therapy, into clinical practice.
+ Topics:
| August 28, 2025 – August 29, 2028 | ||
| Duration | Lecture Title | Speaker(s) |
| 0:25:20 | Early Breast Cancer Locoregional Therapy | Tina Hieken, M.D. |
| 0:35:08 | HER2-Positive Breast Cancer | Pooja Advani, M.B.B.S., M.D. |
| 0:34:02 | Systemic Therapy for TNBC: Curative & Palliative | Roberto Leon Ferre, M.D. |
| 0:37:40 | Systemic Therapy for ER+/HER2 Breast Cancer Therapy | Tufia Haddad, M.D. |
| 0:31:21 | Management of Early-Stage Colorectal Cancer | Jeremy Jones, M.D. |
| 0:34:08 | Advanced Colorectal Cancer (CRC) | Tanios Bekaii-Saab, M.D. |
| 0:35:44 | Upper GI Cancer | Bassam Sonbol, M.D. |
| 0:29:30 | Hepatobiliary Cancers | Mitesh Borad, M.D. |
| 0:24:32 | Pancreatic Cancer 2025 | Robert McWilliams, M.D. |
| 0:31:10 | Update on Management of Early Stage NSCLC | Vinicius Ernani, M.D. |
| 0:37:26 | Advanced Stage IV NSCLC | Rami Manochakian, M.D. |
| 0:24:33 | Small Cell Lung Cancer | Kaushal Parikh, M.B.B.S. |
| 0:23:14 | Other Thoracic Malignancies | Konstantinos Leventakos, M.D., Ph.D. |
| 0:33:42 | Head and Neck Cancer | Katharine Price, M.D. |
| 0:21:24 | Neuro-Oncology | Alyx Porter, M.D. |
| 0:24:05 | Sarcoma | Steve Robinson, M.B.B.S. |
| 0:28:42 | Bladder Cancer Update | Parminder Singh, M.D. |
| 0:32:57 | RCC in 2025: What’s New for the Practicing Oncologist? | Yousef Zakharia |
| 0:26:04 | Germ Cell Cancers | Lance Pagliaro, M.D. |
| 0:33:24 | Prostate Cancer Board Review | Dan Childs, M.D. |
| 0:40:18 | Ovarian Cancer | Andrea Wahner Hendrickson, M.D. |
| 0:28:42 | Updates in Endocrine Malignancies | Mabel Ryder, M.D. |
| 0:26:59 | Hereditary Cancer Syndromes | Siddhartha Yadav, M.B.B.S., M.D. |
| 0:28:43 | Transfusion Medicine for Hematologist/Medical Oncologist | Jeffrey Winters, M.D. |
| 0:34:13 | Management of Thrombosis in Cancer | Aneel Ashrani, M.D., M.S. |
| 0:30:05 | Palliative Care and Symptom Management | Jacob Strand, M.D. |
| 0:23:25 | Hodgkin Lymphoma | Stephen Ansell, M.D., Ph.D. |
| 0:32:04 | Aggressive B-Cell Lymphoma | Grzegorz Nowakowski, M.D. |
| 0:24:53 | Chronic Lymphocytic Leukemia | Sameer Parikh, M.B.B.S. |
| 0:29:58 | Follicular and Mantle Cell Lymphoma Update | Thomas Witzig, M.D. |
| 0:25:11 | Other Indolent Non-Hodgkin Lymphomas | Thomas Habermann, M.D. |
| 0:20:55 | T cell lymphoma | Allison Rosenthal, D.O. |
| 0:26:33 | MGUS / Smoldering Myeloma | Angela Dispenzieri, M.D. |
| 0:30:59 | Newly Diagnosed Multiple Myeloma | Vivek Roy, M.D. |
| 0:38:27 | CAR-T in Myeloma | Yi Lin, M.D., Ph.D. |
| 0:25:53 | Waldenström’s Macroglobulinemia and Amyloidosis | Morie Gertz, M.D. |
| 0:34:40 | Myeloproliferative Neoplasms, Mastocytosis, and Eosinophilic Disorders | Ayalew Tefferi, M.D. |
| 0:30:10 | Myelodysplastic Syndromes and Bone Marrow Failure States – 2025 Updates | Mrinal Patnaik, M.B.B.S. |
| 0:19:22 | Chronic Myeloid Leukemia | Kebede Begna, M.D. |
| 0:23:12 | Acute Myeloid Leukemia | Naseema Gangat, M.B.B.S. |
| 0:33:38 | Update in Acute Lymphoblastic Leukemia | Mark Litzow, M.D. |
| 0:29:58 | Transplantation for Hematologic Disorders Including GVHD | William Hogan, M.B., B.Ch. |
| 0:27:08 | HLH Porphyrias / Acquired Thrombocytopenia (ITP) | Alexandra Wolanskyj-Spinner, M.D. |
| 0:26:46 | Platelet Disorders | Meera Sridharan, M.D., Ph.D. |
| 0:25:18 | Coagulation Factor Disorders: Molecular Basis, Inherited & Acquired Bleeding Disorders | Rajiv Pruthi, M.B.B.S. |
| 0:29:53 | Hemoglobinopathies | Ewa Wysokinska, M.D. |
| 0:26:00 | Nutritional Anemias and Iron Disorders | Ronald Go, M.D. |
| 0:28:54 | Immune Hemolytic Anemia | Surbhi Shah, M.B.B.S. |
| 28:00:23 Content Hours | ||
